FEBS Letters
Volume 582, Issue 1 , Pages 2-9, 9 January 2008

Nuclear receptors: Decoding metabolic disease

Edited by Laszlo Nagy and Peter Tontonoz

Howard Hughes Medical Institute and Gene Expression Laboratory, The Salk Institute for Biological Studies, 10010N. Torrey Pines Road, La Jolla, CA 92037, USA

Received 28 June 2007; accepted 6 November 2007. published online 15 November 2007.

Abstract 

Nuclear receptors (NR) are a superfamily of ligand-activated transcription factors that regulate development, reproduction, and metabolism of lipids, drugs and energy. The importance of this family of proteins in metabolic disease is exemplified by NR ligands used in the clinic or under exploratory development for the treatment of diabetes mellitus, dyslipidemia, hypercholesterolemia, or other metabolic abnormalities. Genetic studies in humans and rodents support the notion that NRs control a wide variety of metabolic processes by regulating the expression of genes encoding key enzymes, transporters and other proteins involved in metabolic homeostasis. Current knowledge of complex NR metabolic networks is summarized here.

Keywords: Orphan nuclear receptor, Metabolic syndrome, Obesity, Insulin resistance, Dyslipidemia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(07)01160-X

doi:10.1016/j.febslet.2007.11.016

FEBS Letters
Volume 582, Issue 1 , Pages 2-9, 9 January 2008